Dr. Carl June | CureTalks
Dr.Carl June is a Richard W. Vague Professor in Immunotherapy, Director; Center for Cellular Immunotherapies; and Director, Parker Institute for Cancer Immunotherapy at the University of Pennsylvania Perelman School of Medicine. Dr. June graduated from the US Naval Academy in 1975 and served as a naval officer before graduating from Baylor College of Medicine in 1979. He studied immunology and malaria with Dr. Paul-Henri Lambert at the World Health Organization in Switzerland and did a postdoc in transplantation biology with Dr. E. Donnell Thomas and Dr. John Hansen at the Fred Hutchinson Cancer Center in Seattle. He was the head of the department of immunology at the Naval Medical Research Institute from 1990 to 1995. He was a professor of medicine and cell and molecular biology at the Uniformed Services University for the Health Sciences before becoming a tenured professor at the University of Pennsylvania in 1999. Dr. June’s research interests are lymphocyte biology, with a major translational focus on ex vivo T-cell engineering for cancer and HIV cell based therapies. His Lab at the Leonard and Madlyn Abramson Family Cancer Research Institute at the Abramson Cancer Center at the University of Pennsylvania, is primarily responsible for developing new Chimeric Antigen Receptors (CARs) and new vectors for current and proposed indications. In addition, his research focuses on developing ways to enhance the ability of the natural immune system to recognize and eliminate tumor cells. Dr. June’s lab provides researchers with the tools they need to translate laboratory insights into safe and effective cancer therapies.
FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms…